PPARGC1A and depressive symptom measurement: This agrees to the results of studies by Fang et al. [46], Odaira et al. [47], and Agudelo et al. [48], which indicates that the AMPK /PGC-1 signaling pathway factor is activated by chronic stress and that AMPK energy metabolism pathway disorders happen in the skeletal muscles of depression patients.